| Name: | Abiraterone Mesylate |
| Catalogue No. | VL830040 |
| CAS No. | N/A |
| Molecular Formula | C25H33NO3S |
| Molecular Weight | 427.6 |
| Status | Under Development |
| IUPAC Name | (3S,10R,13S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl methanesulfonate |
| Description | Abiraterone Mesylate(CAS No: N/A) or (3S,10R,13S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl methanesulfonate, it is a active inhibitor of the steroidal enzyme CYP17A1 and is used in the treatment of prostate cancer. |
| References | Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.” Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067. |
